# Houlihan Lokey Inc. (HLI) — Investment Thesis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-18  
**Tier:** Free primer (steps 1 & 3 of 19)  
**Sibling pages:** /stocks/HLI/financials · /stocks/HLI/memo

> This page shows the free thesis context (business model + recent catalysts).
> The full investment thesis (moat analysis, DCF, scenarios, risk register) is available
> via GET /api/v1/research/HLI/memo ($2.00, Bearer token).

## Business Model

---
ticker: HLI
step: 01
generated: 2026-05-13
source: quick-research
---

### Houlihan Lokey Inc. (HLI) — Business Overview

*Note: Houlihan Lokey's fiscal year ends March 31.*

#### Business Description
Houlihan Lokey is an independent investment bank focused on the middle market, operating three business segments: **Corporate Finance** (~64% of revenue — M&A advisory, capital solutions), **Financial Restructuring** (~23% — #1 global restructuring advisor by deal count), and **Financial & Valuation Advisory** (~13% — fairness opinions, portfolio valuation). The firm is the #1 Global M&A Advisor by deal count (415 deals in 2024), #1 Global Restructuring firm (88 deals in 2024), and #1 Global Fairness Opinion firm since 2000. FY2025 (ended March 31, 2025) revenues were a record $2.39B (+25% YoY). 2,702 employees across 35 locations worldwide.

#### Revenue Model
Pure fee-based advisory: (1) **Corporate Finance fees** — success fees on M&A, divestitures, private equity sponsor advisory; dominant and cyclical, grew 36%+ YoY in Q3 FY2025. (2) **Financial Restructuring fees** — success fees on Chapter 11, out-of-court restructuring, distressed debt exchanges; genuinely counter-cyclical; #1 in restructuring provides a floor during M&A downturns. (3) **FVA fees** — fairness opinion fees (mandated by boards for major transactions) + portfolio valuation for PE firms + transaction advisory; quasi-recurring because fairness opinions are required for virtually every M&A transaction. No balance sheet risk — all revenue is advisory fee-based.

#### Products & Services
- **M&A Advisory** — middle market ($100M–$5B deals); buy-side, sell-side, and sponsor coverage; 415 deals in 2024 (more deals than Goldman Sachs)
- **Capital Solutions** — debt and equity capital raises for middle-market companies
- **Restructuring** — distressed debt restructuring, Chapter 11 debtor/creditor advisory; #1 global by count (88 deals in 2024 vs. PJT's 59)
- **Fairness Opinions** — board-directed opinions on deal fairness; required for all major transactions; #1 since 2000 (1,243 deals cumulative)
- **Portfolio Valuation** — fair value opinions for PE fund portfolios; quarterly/annual recurring revenue from PE firms
- **Financial & Valuation Advisory** — dispute resolution consulting, real estate valuation, transaction advisory
- **Data & Analytics** — leveraging deal data for competitive insights

#### Customer Base & Go-to-Market
Middle-market corporates, private equity sponsors (financial sponsors are the dominant client for all three segments), boards of directors (fairness opinions), creditors and debtors in distress situations. The PE sponsor relationship is the core go-to-market: each PE-backed company is a potential M&A, restructuring, and fairness opinion client. With thousands of PE-backed portfolio companies and ~$6T in PE dry powder deploying, the middle-market deal pipeline is deep.

#### Competitive Position
Houlihan Lokey's three-segment structure creates a rare all-weather advisory model: Corporate Finance wins in bull markets, Restructuring wins in downturns, and FVA provides quasi-recurring revenue in all environments. No other independent advisory firm has the same depth in all three segments simultaneously. Competitors: Evercore and Lazard (advisory), PJT Partners (restructuring), Duff & Phelps/Kroll (valuation). The #1 deal count rankings in M&A and Restructuring create a self-reinforcing reference position: clients choose Houlihan Lokey because everyone else does — particularly boards seeking defensibility in fairness opinions.

#### Key Facts
- Founded: 1972 (Los Angeles)
- Headquarters: Los Angeles, California; New York; Chicago
- Employees: 2,702
- Exchange: NYSE
- Sector / Industry: Financials / Independent Investment Banking Advisory
- Market Cap: ~$14–17B

## Recent Catalysts

---
ticker: HLI
step: 12
generated: 2026-05-13
source: quick-research
---

### Houlihan Lokey Inc. (HLI) — Investment Catalysts & Risks

#### Bull Case Drivers

1. **All-Weather Model + #1 Restructuring = Defensive Growth Regardless of Cycle** — Houlihan Lokey's three-segment structure is uniquely resilient: Corporate Finance wins during M&A bull markets, Restructuring wins during economic stress, and FVA generates quasi-recurring revenue in all environments. When the M&A cycle turns down, Houlihan Lokey's Restructuring backlog (already elevated with 88 deals in 2024) accelerates — because economic stress drives corporate distress. This counter-cyclicality means HLI is one of the few investment banks where a recession scenario doesn't map to a catastrophic earnings decline. The PE sponsor-coverage model (covering thousands of PE-backed portfolio companies) ensures a pipeline of mandates regardless of which direction the credit cycle runs.

2. **Middle Market M&A Leadership + PE Dry Powder = Sustainable Deal Volume** — Houlihan Lokey is the #1 M&A advisor by deal count (415 deals vs. Goldman Sachs' 371 in 2024) — driven by its dominance in the middle market ($100M–$5B transactions). The middle market is structurally more active than mega-deals: more companies, more PE sponsors, more transactions, and less competition from bulge brackets that prefer $10B+ deals. With ~$6T in PE dry powder and lower-middle-market sponsor sentiment improving, the transaction pipeline is robust. The 25% increase in closed transactions in FY2025 (driving +25% revenue) demonstrates that HLI is capturing market share as the M&A cycle recovers, not just riding the cycle.

3. **Fairness Opinion Franchise + FVA Recurring Revenue = Revenue Floor** — The Financial & Valuation Advisory segment (~13% of revenue) provides genuine recurring revenue: fairness opinions are required by boards for every material M&A transaction (HLI is #1 with 1,243 since 2000), and portfolio valuation services for PE firms are contracted quarterly/annually regardless of deal activity. This creates a ~$300M+ annual revenue floor that exists even in down M&A years — covering a large portion of fixed costs before any deal revenues are counted. No competitor combines M&A advisory leadership with fairness opinion and portfolio valuation at this scale.

#### Bear Case Risks

1. **Recession + M&A Freeze = Corporate Finance Revenue Cliff** — While Restructuring provides a counter-cyclical buffer, it takes 6–12 months for a rising tide of corporate distress to flow through to closed Restructuring fees. In the near-term, a sudden M&A freeze (recession, credit crunch, tariff shock) would cause Corporate Finance revenues to drop sharply (64% of revenue) while Restructuring revenues lag. FY2023 demonstrated this: revenues grew only 0.6% YoY when M&A activity was sluggish. At HLI's current ~29–33x trailing P/E, any revenue guidance miss or deal timing slippage could cause meaningful multiple compression, as the market prices a structural peak rather than a cyclical peak.

2. **Premium Valuation + Boutique Size = Limited Multiple Expansion** — Houlihan Lokey trades at ~29–33x trailing P/E — a significant premium to Evercore (~18x) and Lazard (~17x). The market prices HLI as a higher-quality business (all-weather model, market share leadership) but this premium leaves limited room for further re-rating upward. UBS's $163 bear target (vs. $217 average) reflects the view that at current prices, the stock fully prices the M&A cycle recovery and the all-weather model advantage. If EPS growth in FY2026 comes in at 10–15% (vs. 40% in FY2025), the stock could underperform the market even as the business remains fundamentally sound.

3. **Compensation Competition + Talent Retention = Cost Inflation Risk** — Middle-market boutique advisory is a talent war: star MDs at Houlihan Lokey can be poached by Evercore, Moelis, or PJT Partners, or choose to start their own shops. Houlihan Lokey's 2,702 employees and structured culture are retention advantages, but compensation is ultimately the key variable. In the current M&A supercycle, senior banker comp demands are rising across all boutiques. If HLI's comp ratio (traditionally ~55–60%) rises toward Lazard's ~65% due to talent competition, EPS growth would be materially slower than revenue growth. The scale advantage (2,702 employees vs. Lazard's 3,300 but in a more focused model) provides some protection, but the talent market is tight.

#### Upcoming Events
- **Q3 FY2026 earnings** (calendar Q1 2026 results): Revenue growth rate vs. FY2025 record comparisons
- **Restructuring backlog**: Conversion of the elevated backlog from 2024–2025 into closed fees
- **M&A deal count**: Q1 2026 league table position — maintaining #1 by count?
- **New managing director hires**: Any notable additions or departures in Corporate Finance
- **FVA revenue**: Portfolio valuation for PE clients — any growth in contracted services?
- **International expansion**: Any new offices or M&A advisory lateral hires in Europe/Asia?

#### Analyst Sentiment
Buy consensus with valuation debate: 7 analysts, avg PT $216.80, range $163 (UBS, Neutral) to $235 (bull); Buy consensus. UBS is notably more cautious on valuation grounds ($163, flagging premium P/E). The majority of analysts are bullish on HLI's all-weather business model, middle-market M&A leadership, and PE dry powder tailwind. The valuation debate (29–33x P/E for a cyclical advisory business) is the key disagreement — bears argue the premium is unwarranted given M&A cyclicality, bulls argue the defensive Restructuring + FVA combination deserves a structurally higher multiple.

#### Research Date
Generated: 2026-05-13

## Full Investment Thesis (Premium)

The full research tier adds these thesis-critical dimensions:

- Moat Analysis — durable competitive advantages, switching costs, network effects
- Investment Thesis — variant perception, what has to be true, why market may be wrong
- Bull / Base / Bear Scenarios — probability weights, catalysts, price targets
- Risk Register — macro, competitive, execution, regulatory risks with materiality ratings
- Management Quality — capital allocation track record, incentive alignment
- DCF Valuation — 10-year model with sensitivity matrix

**API endpoint:** GET /api/v1/research/HLI/memo

## Navigation

- Overview: /stocks/HLI
- Financials: /stocks/HLI/financials
- Thesis (this page): /stocks/HLI/thesis
- Investment Memo: /stocks/HLI/memo
- Coverage universe: /stocks